Related Experiment Video
Updated: Dec 31, 2025
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
14.9K
Single-Institution Experience of Synovial Sarcoma
Amy Farkas1, Seth T Lirette1, Youssef Al Hmada1
1From the Departments of Radiology, Data Science, Pathology, Pediatric Oncology, Orthopedic Surgery, and Radiation Oncology, University of Mississippi Medical Center, Jackson.
Southern Medical Journal
|January 4, 2020
Summary
Large tumors and older age at diagnosis indicate a poorer prognosis for patients with synovial sarcoma. This study found higher rates of nonextremity disease and lower survival compared to national averages, highlighting a significant challenge.
Area of Science:
- Orthopedics
- Oncology
- Pathology
Background:
- Synovial sarcoma is a rare soft tissue sarcoma.
- Understanding patient demographics and outcomes is crucial for improving treatment strategies.
Purpose of the Study:
- To investigate the patient population and outcomes of synovial sarcoma at a single institution.
- To identify factors influencing prognosis in synovial sarcoma.
Main Methods:
- Retrospective review of medical records for 28 patients diagnosed between 1992 and 2017.
- Analysis of demographics, staging, disease location, treatment, and response to treatment.
Main Results:
- Larger tumor size at presentation was associated with an increased risk of death.
- Increasing patient age was also a factor in poor prognosis.
- The patient cohort exhibited a higher incidence of nonextremity disease and lower overall survival rates compared to national averages.
Conclusions:
- Nonextremity disease and large tumor size at presentation may explain the observed disparity in institutional outcomes.
- Advanced presentation of synovial sarcoma remains a significant challenge for improving patient survival.
